Does CTO-PCI compared to non-CTO-PCI affect clinical and angiographic outcomes in patients undergoing percutaneous coronary intervention?
CTO-PCI is associated with higher target lesion revascularization but lower myocardial infarction rates at 12 months compared to non-CTO-PCI, alongside inferior angiographic outcomes.
CTO-PCI was independently associated with significantly higher rates of TLR as well as a significantly lower incidence of MI at 12-month follow-up. Quantitative coronary angiography analysis of surveillance angiography showed superior angiographic outcomes after non-CTO-PCI.
Aytekin et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: